Vericel (VCEL) Net Cash Flow (2010 - 2026)
Vericel's (VCEL) quarterly Net Cash Flow came in at $9.2 million in Q1 2026, up 272.21% year-on-year from $2.5 million in Q1 2025, and up 3059.16% quarter-over-quarter from -$311000.0 in Q4 2025.
Vericel (VCEL) Net Cash Flow (2010 - 2026) Analysis & Trends
Vericel has disclosed Net Cash Flow across 17 years of filings, most recently posting $9.2 million for Q1 2026.
- Net Cash Flow for Q1 2026 came in at $9.2 million, up 272.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $29.6 million (up 230.13% YoY), and the FY2025 annual result was $15.0 million, up 927.9% from the prior year.
- Net Cash Flow came in at $9.2 million for Q1 2026 at Vericel, up from -$311000.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $19.9 million in Q3 2025 to a low of -$16.1 million in Q1 2024.
- The 5-year median for Net Cash Flow is $3.0 million (2022), against an average of $2.4 million.
- Across the five-year window, Net Cash Flow jumped 2174.18% in 2023 and plunged 249.75% in 2024, its largest moves.
- Vericel's Net Cash Flow stood at -$14.1 million in 2022, then surged by 123.36% to $3.3 million in 2023, then soared by 344.75% to $14.7 million in 2024, then slumped by 102.12% to -$311000.0 in 2025, then jumped by 3059.16% to $9.2 million in 2026.
- The last three Net Cash Flow figures came in at $9.2 million (Q1 2026), -$311000.0 (Q4 2025), and $19.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | 9.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.20 Mn |
| Mar 31, 2026 | 9.20 Mn |
| Dec 31, 2025 | -311,000.00 |
| Dec 31, 2025 | -311,000.00 |
| Sep 30, 2025 | 19.87 Mn |
| Sep 30, 2025 | 19.87 Mn |
| Jun 30, 2025 | 827,000.00 |
| Jun 30, 2025 | 827,000.00 |
| Mar 31, 2025 | -5.34 Mn |
| Mar 31, 2025 | -5.34 Mn |
| Dec 31, 2024 | 14.70 Mn |
| Dec 31, 2024 | 14.70 Mn |
| Sep 30, 2024 | -5.50 Mn |
| Sep 30, 2024 | -5.50 Mn |
| Jun 30, 2024 | 5.11 Mn |
| Jun 30, 2024 | 5.11 Mn |
| Mar 31, 2024 | -16.12 Mn |
| Mar 31, 2024 | -16.12 Mn |
| Dec 31, 2023 | 3.31 Mn |
| Dec 31, 2023 | 3.31 Mn |